Pradžia › Mažų ląstelių plaučių vėžys › Pennsylvania
Mažų ląstelių plaučių vėžys klinikiniai tyrimai Pennsylvania
15 tyrimai dėl Mažų ląstelių plaučių vėžys ieško dalyvių vietose Pennsylvania.
Miestai Pennsylvania
Oficialus tyrimo tekstas (anglų kalba)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
- WellSpan York Cancer Center, York
Renkami dalyviai1/2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT04585750A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
Renkami dalyviai1 fazė
Amžius 19 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06586957DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- AHN Cancer Institute - Allegheny General, Pittsburgh
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07472517DESTINY-PANTUMOUR04
- Research Site, Philadelphia
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07124000A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- St. Lukes University Hospital /ID# 280204, Bethlehem
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT07365241A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Consultants in Medical Oncology and Hematology, Broomall
- Alliance Cancer Specialists, Media
- Allegheny General Hospital, Pittsburgh
- ir dar 1
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT07218146AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Philadelphia
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-04 · NCT07038343Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- St. Luke's Physician Group - St. Luke's Cancer Care Associates, Fountain Hill
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT06712355Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
- Fox Chase Cancer Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
- Guthrie, Sayre
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-28 · NCT07057791A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-09 · NCT07174583Tempus Small Cell Lung Cancer Observational Study (Sculptor)
- Cancer Care Association of York, York
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-15 · NCT05257551Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
- Fox Chase Cancer Center, Philadelphia
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-22 · NCT05800587Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-11 · NCT06681220Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- University of Pennsylvania, Philadelphia
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-18 · NCT07030257VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Cancer Care Associates of York (site 206), York
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2025-12-11 · NCT03556228Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.